A5005970803- Autoimmune Bullous Skin Diseases
- Dermatology and Skin Diseases
- Nail Diseases and Treatments
- Eosinophilic Esophagitis
- Liver Disease Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Hidradenitis Suppurativa and Treatments
- Colorectal and Anal Carcinomas
- Skin Diseases and Diabetes
- Cutaneous lymphoproliferative disorders research
- Psoriasis: Treatment and Pathogenesis
- Drug-Induced Adverse Reactions
- Immunodeficiency and Autoimmune Disorders
- Systemic Sclerosis and Related Diseases
- Tissue Engineering and Regenerative Medicine
- Asthma and respiratory diseases
- Corneal Surgery and Treatments
- Chemotherapy-related skin toxicity
- Cytomegalovirus and herpesvirus research
- Eosinophilic Disorders and Syndromes
- Mesenchymal stem cell research
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Hepatitis C virus research
- Skin and Cellular Biology Research
The University of Texas Southwestern Medical Center
2013-2025
Rutgers, The State University of New Jersey
2019-2025
Rutgers New Jersey Medical School
2022-2025
Southwestern Medical Center
2022-2025
Cornell University
2025
Weill Cornell Medicine
2025
Thomas Jefferson University
2025
Parkland Health & Hospital System
2018
Children's National
2014
552 Background: HIMALAYA showed that D+T and D are effective options for unresectable hepatocellular carcinoma (uHCC). However, data on outcomes according to the adherence inclusion criteria in routine clinical practice lacking. Methods: In context of a prospectively maintained database including 1293 patients (pts) with uHCC treated immunotherapy, we analysed pts or across 8 centres USA, Asia Europe. Pts who met >1 key exclusion criterion (prior systemic therapy, Child-Pugh class B-C,...
Hepatocellular carcinoma (HCC) surveillance is associated with early tumor detection and improved survival in patients cirrhosis; however, effectiveness limited by underuse. We compared the of mailed outreach patient navigation strategies to increase HCC a racially diverse cohort cirrhosis. conducted pragmatic randomized clinical trial comparing for screening ultrasound (n = 600), plus or usual care visit-based 600) among 1800 cirrhosis at large safety-net health system from December 2014...
Background/Objectives: Early-onset cancer is an emerging global health concern, including in the United States. However, data on early-onset liver and intrahepatic bile duct remain limited. This study aims to fill this gap by analyzing trends States over past two decades. Methods: used National Childhood Cancer Registry examine temporal The analysis involved estimating age-adjusted incidence rates of cancer, stratified histological type, ethnicity, sex. Results: In 2021, rate was estimated...
Background & Aims: Immunotherapy has emerged as an effective treatment for advanced hepatocellular carcinoma (HCC). We aimed to investigate the real-world effectiveness of immunotherapy compared lenvatinib in HCC. Approach Result: From TriNetX database, we used a target trial emulation framework and identified HCC patients who received first-line with (atezolizumab/bevacizumab or tremelimumab/durvalumab) between August 2018 December 2023. Overall survival (OS) was using Kaplan-Meier...
Background & Aims: Hepatic fiber morphology may significantly enhance our understanding of molecular alterations in metabolic dysfunction-associated steatotic liver disease (MASLD). We aimed to comprehensively characterize hepatic morphological phenotypes MASLD and their associated using multi-layer omics analyses. Approach Results: To quantify the fibers, artificial intelligence-based FibroNest algorithm (PharmaNest) was applied 94 MASLD-affected biopsies, among which 12 (13%) had...
Background: The RETREAT score is a simple risk stratification tool for post-liver transplantation (LT) hepatocellular carcinoma (HCC) recurrence that has been validated in retrospective cohort studies. A prospective, multicenter study needed to further demonstrate accuracy especially given evolving clinical demographics and HCC transplant practice. Aim: To validate compare the other post-LT scores contemporary, prospective of patients Approach: We prospectively enrolled from 8 centers...
Introduction: Herpetic whitlow, due to herpes simplex virus (HSV) type 1 or 2, typically presents with vesicles that may coalesce into bullae. whitlow often resolves without intervention but can be treated antiviral medications. Case presentation: Herein is a report of 68-year-old female patient history well controlled human immunodeficiency (HIV) infection and 4-year recurrent HSV-2 genitalis who failed multiple trials standard therapy clinically confirming case resistant infection, tender...